Anti-allergic Impurity-Ebastine

Ebastine is patented in 1983 by Almirall S.A and came into medical use in 1990.Ebastine is a second-generation H1 receptor antagonist that is indicated mainly for allergic rhinitis and chronic idiopathic urticaria.

We manufacture and furnish high quality Ebastine impurity for global markets. More information is available on the official website: https://www.ex-biotech.com. If you have any questions, please send an email to sale@ex-biotech.com. We are looking forward to cooperating with you.

The following are some of the impurities of Ebastine :